Growth Watchlist update – Macquarie Group MQG:ASX
Earnings update for Macquarie group MQG:ASX
Earnings update for Macquarie group MQG:ASX
Kai Chen and Mark Gardner talk about the next phase of AI investment
Business update for Telix pharma TLX:ASX
BUY 5% Intl Quality ETF (QUAL)
BUY 5% CSL (CSL)
ADD 2.5% Johns Lyng Grp (JLG)
Switch URNM ETF to Paladin
This action secures a solid 25% profit on half of our investment, aligning with our initial risk management and profit-taking strategy. By locking in gains, we protect our portfolio against unforeseen market volatilities while capitalizing on our successful positioning.
With Paladin delivering production on time and the major components of URNM having production difficulties, we are recommending a switch back to Paladin (PDN)
Given these dynamics, transitioning from Paladin Energy to the Uranium ETF (URNM) is recommended for those seeking to maintain exposure to the uranium sector while managing risk more effectively. URNM offers a diversified investment in uranium and nuclear energy stocks, thereby reducing the volatility associated with individual stock performances like Paladin’s. This move aligns with a strategy to capitalize on the thematic growth of the uranium sector while mitigating risk through diversification.
Uranium stocks have started to pull back from the most recent run up. Looking for good areas of support to buy PDN as longer term supply deficit in Uranium is still in play
A recent rally in the underlying Uranium price. The we have hit the recent highs for Paladin and recommend taking our position off as it has hit profit target.
A recent rally in the underlying Uranium price. We are generally bullish the energy sector and see PDN as a short term buy with a ~10% trailing stop
General market risk-off, global bond yields have reach new multi-year high causing a sell off in risky assets.
A recent rally in the underlying Uranium price. The we have hit the recent highs for Paladin and recommend taking half our position off for a quick scalp.